↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Spain PLACE contract award · ocds-ted-512291-2025

Spain – Pharmaceutical products – 2ª Prorroga (adelantada) Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMAR

Hospital Clínico San Carlos de Madrid awarded €326K to BIOGEN SPAIN, S.L. for Construction & Public Works in August 2025 — one of 764 awards this buyer has made, above its typical award size.

Construction & Public Works
05 Aug 2025
Award date
€326K
Contract value

Buying agency

Hospital Clínico San Carlos de Madrid
764 Awards
€365K Avg award
Above vs typical

Winning supplier

BIOGEN SPAIN, S.L.
77 Awards
36 Buyers
€45.1M Total won

Contract description

Spain – Pharmaceutical products – 2ª Prorroga (adelantada) Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid

Premium

Related awards · Hospital Clínico San Carlos de Madrid

764 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

720 more awards from this buyer · full history & CSV export

Premium

Other wins · BIOGEN SPAIN, S.L.

77 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Hospital Clínico San Carlos de Madrid and BIOGEN SPAIN, S.L. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up